Based on our studies of FLEC in single RyR2 channels and isolated Casq2-/- myocytes, we proposed that Na+ and RyR2 channel block have additive effects and together are contributing for FLEC’s striking clinical efficacy in CPVT [22]. The gene discussed is CASQ2; the disease is catecholaminergic polymorphic ventricular tachycardia.